Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.97 AUD | -1.83% | +4.50% | +13.17% |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.17% | 375M | |
+20.14% | 21.89B | |
+13.49% | 14.45B | |
+12.63% | 13.63B | |
+38.81% | 11.49B | |
-8.86% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.06B | |
-5.36% | 4.66B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma Group Narrows Loss in Six Monts to December 2021